Atherosclerosis Supplements, 1567-5688

Tidskrift

Fler filtreringsmöjligheter
  1. 2004
  2. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

    Alexandru Schiopu, J. Bengtsson, Ingrid Söderberg, Sabina Janciauskiene, S. Lindgren, Mikko Ares, P.K. Shah, R. Carlsson, Jan Nilsson & Gunilla Nordin Fredrikson, 2004, I : Atherosclerosis Supplements. 5, 1, s. 42

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  3. 2005
  4. Association between IGM against an aldehyde-modified peptide sequence in apo B-100 and progression of carotid disease

    GN Fredrikson, Bo Hedblad, Göran Berglund, R Alm, JA Nilsson, Alexandru Schiopu, PK Shah & J Nilsson, 2005, I : Atherosclerosis Supplements. 6, 1, s. 65-65

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  5. 2006
  6. Atherogenic effects of upper respiratory infections and passive smoking in children with type 1 diabetes mellitus

    Michal Odermarsky, Stefan Willers & Petru Liuba, 2006 jun, I : Atherosclerosis Supplements. 7, 3, s. 351 1 s., We-P11:24.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  7. 2009
  8. A Novel Mutation In CETP Gene As A Cause Of CETP Deficiency In A Caucasian Kindred

    P. Tarugi, M. Gomaraschi, Peter Nilsson, E. Favari, M. P. Adorni, F. Bernini, C. Sirtori, G. Franceschini & L. Calabresi, 2009, I : Atherosclerosis Supplements. 10, 2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  9. Anticoagulant Properties Of Apolipoprotein A-I And Phospholipid Transfer Protein

    Cecilia Oslakovic, Michael Krisinger, M. Jauhiainen, C. Ehnholm & Björn Dahlbäck, 2009, I : Atherosclerosis Supplements. 10, 2, s. e138-e138

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  10. Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions

    Daniel Kolbus, Maria Wigren, Jan Nilsson & Gunilla Nordin Fredrikson, 2009, I : Atherosclerosis Supplements. 10, 2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  11. Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction

    Harry Björkbacka, E. Lavant, Gunilla Nordin Fredrikson, Olle Melander, Göran Berglund, Jonas Carlson & Jan Nilsson, 2009, I : Atherosclerosis Supplements. 10, 2, s. e953-e953

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  12. Diet-Induced Hyperlipidemia Activates Myd88-Dependent Innate Immune Signaling Resulting In Increased Leukocyte Rolling In Vivo

    Adrian Pistea, Katarina Berg, Marie Lindholm, Anna Zetterqvist, Jenny Öhman, Maria Gomez, Jan Nilsson, Henrik Thorlacius & Harry Björkbacka, 2009, I : Atherosclerosis Supplements. 10, 2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  13. Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization

    Maria Wigren, Daniel Kolbus, Pontus Dunér, Harry Björkbacka, Gunilla Nordin Fredrikson & Jan Nilsson, 2009, I : Atherosclerosis Supplements. 10, 2, s. e885-e885

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  14. Expression Of Apolipoprotein M In Fetal Liver: Impact Of Maternal Diabetes

    C. Christoffersen, M. Lindegaard, Olof Axler, P. Damm, Björn Dahlbäck & L. Nielsen, 2009, I : Atherosclerosis Supplements. 10, 2, s. e714-e714

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  15. FCGAMMARIIB Inhibits The Development Of Atherosclerosis In Mice

    Ming Zhao, Harry Björkbacka, Jan Nilsson & Gunilla Nordin Fredrikson, 2009, I : Atherosclerosis Supplements. 10, 2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  16. HDL From Carriers Of The R37X Mutation In CETP Gene And Endothelial Cell Homeostasis

    L. Calabresi, S. Pozzi, Peter Nilsson, C. Sirtori, G. Franceschini & M. Gomaraschi, 2009, I : Atherosclerosis Supplements. 10, 2

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  17. ION Mobility Analysis Of Lipoprotein Subfractions Suggests Three Independent Mechanisms Of Cardiovascular Risk

    K. Musunuru, Marju Orho-Melander, M. Caulfield, R. Reitz, Göran Berglund, Bo Hedblad, Gunnar Engström, S. Kathiresan, Olle Melander & R. Krauss, 2009, I : Atherosclerosis Supplements. 10, 2, s. e17-e17

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  18. Low Serum Levels Of DHEA Predict Death From Cardiovascular Disease In Older Men

    C. Ohlsson, F. Labrie, E. Barrett-Connor, L. Vandenput & Mikael Karlsson, 2009, I : Atherosclerosis Supplements. 10, 2, s. e268-e268

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  19. Osteopontin Is Pivotal For Development Of Uremic Atherosclerosis

    T. Pedersen, S. Bro, Anna Hultgårdh & L. Nielsen, 2009, I : Atherosclerosis Supplements. 10, 2, s. e1508-e1508

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  20. Recombinant Apolipoprotein M Secretion Stimulated By HDL

    Josefin Ahnström, Olof Axler & Björn Dahlbäck, 2009, I : Atherosclerosis Supplements. 10, 2, s. e1175-e1175

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  21. Relationship Between Plasma Apolipoprotein-M And High Density Lipoprotein Apoa Kinetics In Men

    E. Ooi, G. Watts, D. Chan, L. B. Nielsen, P. Plomgaard, Björn Dahlbäck & H. Barrett, 2009, I : Atherosclerosis Supplements. 10, 2, s. e729-e729

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  22. Structural And Functional Features Of HDL From Carriers Of The R37X Mutation In CETP Gene

    L. Calabresi, E. Favari, F. Bernini, Peter Nilsson, C. Sirtori, P. Tarugi, G. Franceschini & M. Gomaraschi, 2009, I : Atherosclerosis Supplements. 10, 2, s. e236-e236

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  23. 2010
  24. ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION

    Cecilia Oslakovic, M. Jauhiainen, C. Ehnholm & Björn Dahlbäck, 2010, I : Atherosclerosis Supplements. 11, 2, s. P233

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  25. ASSOCIATION OF VARIOUS POLYMORPHISMS WITH CAD IN NORTH INDIAN POPULATION: REPLICATION OF SNPS IDENTIFIED THROUGH GENOME WIDE ASSOCIATION STUDIES

    Jitender Kumar, S. Yumnam, T. Basu, A. Ghosh, G. Garg, G. Karthikeyan & S. Sengupta, 2010, I : Atherosclerosis Supplements. 11, 2, s. P167

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  26. BODY FAT RELATED TO RISK FACTORS FOR CVD IN YOUNGER CHILDREN

    Magnus Dencker, Ola Thorsson, Magnus Karlsson, Christian Lindén, Per Wollmer & L. B. Andersen, 2010, I : Atherosclerosis Supplements. 11, 2, s. MS191

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  27. LDL INCREASES VASCULAR ETB2 RECEPTOR EXPRESSION VIA ACTIVATION OF ERK1/2 AND P38 MAPK PATHWAYS

    Yao Zhang, Jianpu Zheng, W Zhang, Lars Edvinsson & Cang-Bao Xu, 2010, I : Atherosclerosis Supplements. 11, 2, s. P367

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  28. THE ROLE OF SNARE PROTEINS IN HUMAN INSULIN RESISTANCE

    P. Bostrom, L. Andersson, B. Vind, L. Haversen, Y. Wickstrom, E. Larsson, P. -A. Jansson, M. Svensson, R. Branemark, Charlotte Ling, H. Beck-Nielsen, J. Boren, K. Hojlund & S. -O. Olofsson, 2010, I : Atherosclerosis Supplements. 11, 2, s. P283

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract